Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.3.99.3 (
acyl-CoA dehydrogenase
)
1,425
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We report here the identification and characterization of murine
CCX-CKR
, a high affinity receptor for the murine beta-chemokines SLC/mCCL21, MIP-3beta/mCCL19 and TECK/mCCL25. Unlike most other chemokine receptors,
CCX-CKR
is unable to mediate Ca(2+) fluxes upon ligand binding when expressed in HEK293 cells. Murine
CCX-CKR
is expressed predominantly in the heart and lung, but is detectable in most organs using RT-PCR. Interestingly, in brain and testis, an alternative mRNA form of
CCX-CKR
exists with a unique 5' untranslated region (5'UTR) that overlaps with a novel
acyl-CoA dehydrogenase
(
ACD
) gene. Analysis of human
CCX-CKR
shows that the expression profiles and alternative 5'UTR are conserved. However, in man, there are two copies of the
CCX-CKR
gene, one on chromosome 3 nestled within the
ACD
homologue, and one on chromosome 6. These genes encode proteins with only one amino acid difference, and their expression is independently regulated. This study identifies murine
CCX-CKR
, reveals complex regulation of
CCX-CKR
gene expression in mouse and man, and is suggestive of non-leukocytic targets for MIP-3beta/CCL19, SLC/CCL21 and TECK/CCL25.
...
PMID:Characterization of mouse CCX-CKR, a receptor for the lymphocyte-attracting chemokines TECK/mCCL25, SLC/mCCL21 and MIP-3beta/mCCL19: comparison to human CCX-CKR. 1198 10